Med22 Antibodies

Santa Cruz Biotechnology provides a broad selection of Med22 monoclonal antibodies for advanced research in molecular biology. Med22 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Med22, a component of the Mediator complex, plays a crucial role in the regulation of gene expression by serving as a bridge between transcription factors and RNA polymerase II. Its involvement in the transcriptional regulation of various genes makes Med22 essential for cellular processes such as differentiation, proliferation, and response to environmental signals. Understanding the function of Med22 is vital for elucidating the mechanisms underlying various diseases and developing targeted therapies. Med22 monoclonal antibodies enable researchers to investigate specific protein interactions and cellular pathways involved in transcriptional regulation. Studying Med22's role in gene expression can provide insights into potential therapeutic targets for various diseases. Med22 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing our understanding of transcriptional regulation and its impact on human health.